Capricor Therapeutics, Inc. (CAPR)
29.70
-0.34
(-1.13%)
USD |
NASDAQ |
Dec 30, 09:41
Capricor Therapeutics Total Liabilities (Quarterly): 42.57M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 902.34M |
| Inovio Pharmaceuticals, Inc. | 77.11M |
| Perspective Therapeutics, Inc. | 52.61M |
| Arcturus Therapeutics Holdings, Inc. | 57.78M |
| Myomo, Inc. | 19.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.44M |
| Shareholders Equity (Quarterly) | 83.87M |
| Debt to Equity Ratio | 0.2137 |
| Current Ratio | 3.586 |
| Net Debt Paydown Yield | -0.77% |